Be the first to like this
Big Data/Real World Analytics can be the catalyst for dramatic change in U.S. healthcare. Big Data informs many commercial, medical and HEOR decisions. On an average, Pharma Companies use 35-50% of analytics techniques to support commercial, medical and HEOR decisions. Data acquisition and infrastructure represent a majority of spending for Big Data. Data management cost-sharing
across functions could drive savings & boost effectiveness. Howwever, the pharmaceutical industry is still in the early stages of utilizing large data sets from different sources to inform critical aspects of medical, commercial and HEOR operations.
Best Practices, LLC published this study by engaging 22 leaders from 18 pharmaceutical companies through a benchmarking survey. This study aims to produce reliable industry metrics on current and future trends for Big Data utilization across medical, commercial and HEOR groups. A majority of study participants think partnerships with health plans/payers and data aggregators have a high impact on Big Data projects and programs. The respondents said about 20% of data is sourced from partnerships.
Download Full Report: http://bit.ly/2cTW4wR